688410 Stock Overview
Provides integrated blood purification solutions for renal failure and critically ill patients worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
SWS Hemodialysis Care Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.09 |
52 Week High | CN¥24.08 |
52 Week Low | CN¥10.65 |
Beta | 0 |
11 Month Change | -3.25% |
3 Month Change | -26.83% |
1 Year Change | -38.21% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 2.56% |
Recent News & Updates
Shareholder Returns
688410 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | 11.1% | 4.5% | 0.4% |
1Y | -38.2% | -14.7% | -21.0% |
Return vs Industry: 688410 underperformed the CN Medical Equipment industry which returned -15.6% over the past year.
Return vs Market: 688410 underperformed the CN Market which returned -22% over the past year.
Price Volatility
688410 volatility | |
---|---|
688410 Average Weekly Movement | 6.3% |
Medical Equipment Industry Average Movement | 5.2% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 688410's share price has been volatile over the past 3 months.
Volatility Over Time: 688410's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 881 | Guangyong Gao | www.swskj.com |
SWS Hemodialysis Care Co., Ltd. provides integrated blood purification solutions for renal failure and critically ill patients worldwide. It offers blood purification equipment, dialysis disposables, and dialysis center intelligent management system, as well as operates chain dialysis centers. The company was founded in 2001 and is headquartered in Chongqing, China.
SWS Hemodialysis Care Co., Ltd. Fundamentals Summary
688410 fundamental statistics | |
---|---|
Market cap | CN¥3.86b |
Earnings (TTM) | CN¥154.15m |
Revenue (TTM) | CN¥659.16m |
25.1x
P/E Ratio5.9x
P/S RatioIs 688410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688410 income statement (TTM) | |
---|---|
Revenue | CN¥659.16m |
Cost of Revenue | CN¥328.28m |
Gross Profit | CN¥330.88m |
Other Expenses | CN¥176.74m |
Earnings | CN¥154.15m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
Earnings per share (EPS) | 0.48 |
Gross Margin | 50.20% |
Net Profit Margin | 23.39% |
Debt/Equity Ratio | 0% |
How did 688410 perform over the long term?
See historical performance and comparison